Joshua Meeks

TURBT is one of the most impt surgical skills in managing #bladdercancer 2026 course was another big success. Thank you @olympusamerica for your support Incredible group of residents fellows and attendings there this year. Thx @JoshMeeks and John Sfakianos for helping teach

Another great course. Thanks to all our attendees, faculty and staff. @Olympus_Corp

@LauraBukavinaMD @Olympus_Corp organized the course. Would love to have more trainees.

@JoshMeeks This would be great for our residents , how did you arrange this ? With Olympus or this is institutional?

Olympus TURBT Course flex cystoscope and biopsy

More views of these great bladder models

Bladder neck

Some more dome tumors

More dome challenges

Anterior bladder pressure for the dome

Forward facing loop. Can get thin but great for the back wall

Increasing the complexity- back wall.

Lateral resections. Pure cut and staccato

We don’t often need a longer length resectoscope, but when you do…

We’re getting the band back together in Nashville for Uromigos Live & Unplugged 2026! More details coming soon. For now, mark your calendar. #Uromigos #GUOncology #OncologyCommunity

@tonivilaseca presenting promising early data for intravesical erdafitinib (Erda-iDRS) “TAR 210” in NMIBC presented at #EAU26 ➡️ 83% 12-mo RFS as adjuvant therapy in HR NMIBC (n=26) ➡️ 89% CR at 6 months in IR NMIBC ablative cohort Targeted #FGFR therapy moving earlier into NMIBC disease states. @JoshMeeks @DrFelixGuerrero @IBCG_BladderCA @BladderCancerUS

I'm amazed by the progress of #bladdercancer research. I had to revise this paper after #ASCO25, #ESMO25, #GUASCO26. Thank you to @jclinicalinvest for their patience in trying to keep up with discovery. @tompowles1 @MattGalsky @AndreaNecchi @DrRosenbergMSK @UrogerliMD @MichvdHeijden

The changing landscape of #urothelial #carcinoma: on the edge of paradigm shift In this Review Joshua J. Meeks @JoshMeeks @NUFeinbergMed discusses advancements in biomarkers and novel therapeutics that are likely to dramatically improve survival of patients with #Bladder #Cancer: doi.org/10.1172/JCI202…

Truly impressive DFCI GU Oncology team. A special thank you to my host, @DrChoueiri, for a great visit. @mouwlab @VanAllenLab @srviswanathan @bergsa83 @OncoBellmunt @MattMossanen

WE ARE HERE‼️ OncoAlert 🚨is Proud to be collaborating with @AUC3_Official and is NOW coming LIVE from Miami🌴 #AUC3 2026 in full swing ARTICLE HERE: 👉 buff.ly/bAgkPQC JUST OUT on the management of renal cell and urinary tract cancers from the Advanced Urologic Cancer Consensus Conference (AUC3) and the Expert consensus Bienvenidos a Miami☀️ @DrRanaMcKay @montypal @DrRosenbergMSK @Wanling50578056 @Dr_Aggen @AlbigesL @apolo_andrea @OncoBellmunt @bergsa83 @bilenma @BraunMDPhD @drjefstathiou @PGrivasMDPhD @shilpaonc @arihakimi @HHammersMD @DrDanielHeng @MichelleDunno17 @EJonasch @koshkin85 @advocatekidneys @UrogerliMD @SurenaMatinMD @maughanonc @BradMcG04 @JoshMeeks @motzermd @AndreaNecchi @SimaPorten @tompowles1 @brian_rini @sonpavde @ChadTangMD @MichvdHeijden @VincentWenxinXu @TiansterZhang @Mustafajsalehmd @mzugman #kidneyCancer #BladderCancer

Congrats to @SGoswamiMDPhD and @DrByronLee. The mysterious world of COMPASS continues in bladder cancer . Very elegant story focused on KDM6A. @MDAndersonNews nature.com/articles/s4146…

Signing off 2025 on a positive note w/ a discussion around @US_FDA approval of #Enfortumab + Pembro (EV303) in MIBC w/ @tompowles1 (design, findings, AEs, role of ctDNA) Full 🗣️: ⭐️ oncbrothers.com/ev-pembro-mibc… ⭐️ “Oncology Brothers” podcast #BladderCancer @OncUpdates @OncoAlert